List of Tables
Table 1: Immunology Drugs Market, Global, Symptoms of RA, Psoriasis and IBD, 2018 17
Table 2: Immunology Drugs Market, Global, Organ-Specific Symptoms of Transplant Rejection, 2018 18
Table 3: Immunology Drugs Market, Global, Organ-Specific Symptoms of Acute GVHD, 2018 18
Table 4: Immunology Drugs Market, Global, Organ-Specific Symptoms of Chronic GVHD, 2018 19
Table 5: Immunology Drugs Market, Etiology of RA, Psoriasis, IBD and GVHD, 2018 21
Table 6: Immunology Drugs Market, 7MM, Epidemiology of Key Immunology Indications, 2018 27
Table 7: Immunology Drugs Market, Global, Approved Indications for Humira, 2018 41
Table 8: Immunology Drugs Market, Global, Approved Indications for Enbrel, 2018 44
Table 9: Immunology Drugs Market, Global, Approved Indications for Remicade, 2018 46
Table 10: Immunology Drugs Market, Global, Approved Indications for Rituxan, 2018 49
Table 11: Immunology Drugs Market, Global, Approved Indications for Stelara, 2018 51
Table 12: Immunology Drugs Market, Global, Approved Indications for Simponi, 2018 53
Table 13: Immunology Drugs Market, Global, Approved Indications for Orencia, 2018 55
Table 14: Immunology Drugs Market, Global, Approved Indications for Tysabri, 2018 57
Table 15: Immunology Drugs Market, Global, Approved Indications for Actemra, 2018 59
Table 16: Immunology Drugs Market, Global, Approved Indications for Prograf, 2018 61
Table 17: Immunology Drugs Market, Global, Approved Indications for Cimzia, 2018 62
Table 18: Immunology Drugs Market, Global, Approved Indications for Entyvio, 2018 64
Table 19: Immunology Drugs Market, Global, Approved Indications for Cosentyx, 2018 66
Table 20: Immunology Drugs Market, Global, Approved Indications for Otezla, 2018 67
Table 21: Immunology Drugs Market, Global, Approved Indications for Xeljanz, 2018 69
Table 22: Immunology Drugs Market, Global, Approved Indications for Taltz, 2018 70
Table 23: Immunology Drugs Market, Global, Annual Revenue Forecast for Key Products ($m), 2016–2023 103
Table 24: Immunology Drugs Market, Global, Usage of Generics Across Key Indications, 2018 105
Table 25: Immunology Drugs Market, Global, Forecast Revenue by Company (%), 2016–2023 113